Marjolein de Bruijn - Concepedia

Author

Marjolein de Bruijn

Also Known As

Marjolein de Bruijn

Publications

956

Citations

H-Index

Concepts

All Affiliations

Marjolein de Bruijn is an author at Oncode Institute specializing in tumor immunity, cell biology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	386
2	Cell Biology	2	2	386
3	Immunology	1	1	50
4	Cancer Cell Biology	1	1	50
5	Cancer Therapeutics	1	1	336

Marjolein de Bruijn

Publications

952

Citations

H-Index

Page 1

	Year	Citations
Pulmonary innate lymphoid cells are major producers of <scp>IL</scp>‐5 and <scp>IL</scp>‐13 in murine models of allergic asthma Roel G. J. Klein Wolterink, Alex KleinJan, Menno van Nimwegen, European Journal of Immunology	2012	467
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen, Nature Medicine Pd-1 BlockadeMedicineTumor ImmunityImmune Checkpoint InhibitorTumor Targeting	2021	336
SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing Riccardo Mezzadra, Marjolein de Bruijn, Lucas T. Jae, PLoS ONE ImmunoeditingImmunologyCell DeathCouples IfngrTumor Cells	2019	50
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors Paulien Kaptein, Célia Jacoberger-Foissac, Petros Dimitriadis, Science Translational Medicine	2022	50
An adverse tumor-protective effect of IDO1 inhibition Juliana C.N. Kenski, Xinyao Huang, David W. Vredevoogd, Cell Reports Medicine	2023	29
Protocol for ex vivo culture of patient-derived tumor fragments Lisanne M. Roelofsen, Paula Voabil, Marjolein de Bruijn, STAR Protocols	2023	20

Page 1